F16.92
Hallucinogen use, unspecified with intoxication
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F16.92 describes a condition characterized by the use of hallucinogenic substances resulting in intoxication. This classification encompasses scenarios where an individual has consumed hallucinogens, leading to altered perceptions, sensations, and mental states, but without specifying the particular substance involved. Recognizing the signs and implications of hallucinogen intoxication is essential for appropriate healthcare responses and management.
Causes & Symptoms
Clinical Causes: Use of hallucinogenic drugs such as LSD, psilocybin (magic mushrooms), DMT, or peyote. Accidental ingestion of hallucinogenic substances. Intentional recreational or experimental drug consumption. Use of contaminated or adulterated substances containing hallucinogenic properties. Polydrug use involving hallucinogens and other substances like alcohol or stimulants.
Key Symptoms: Visual hallucinations, seeing patterns or creatures that are not real. Auditory disturbances, such as hearing voices or sounds that do not exist. Altered sense of time and space, feeling as if time is speeding up or slowing down. Unusual thoughts or perceptions, including paranoia or delusions. Dilated pupils and rapid heartbeat. Impaired judgment and coordination, leading to potential safety risks. Increased emotional sensitivity or unpredictable mood swings. Nausea, dizziness, or gastrointestinal discomfort.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical evaluation, patient history, and observed symptoms. Healthcare providers assess recent substance use, physical signs of intoxication, and may perform urine or blood tests to detect hallucinogenic substances. Differential diagnosis helps distinguish hallucinogen intoxication from other psychiatric or neurological conditions presenting with similar symptoms.
Treatment Protocols: Management of hallucinogen intoxication focuses on supportive care. This may include ensuring a safe environment, managing agitation or distress, and monitoring vital signs. In some cases, medications may be administered to address severe agitation or psychosis. Long-term treatment might involve counseling or mental health support to address underlying issues related to substance use. Importantly, there is no specific antidote for hallucinogens, emphasizing the importance of prompt supportive care.
Clinical Advice & FAQs
Billing Guidance
Is F16.92 a billable ICD-10 code?
Yes, F16.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.92?
Clinical documentation must specify the nature of Hallucinogen use, unspecified with intoxication and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
